... Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate — Clinical Cancer Research Sprycel Patient Tips — Drugs.com ...
... Dasatinib (Imkeldi, Sprycel) — Take Imkeldi with a meal and a large glass of water. Take Sprycel with or without food. Imatinib (Gleevec) — Take with a meal and a large glass of water. Ponatinib (Iclusig) — Take with or without food. ...
How Fasting Affects People Taking CML Treatment
... Dasatinib (Imkeldi, Sprycel) — Take Imkeldi with a meal and a large glass of water. Take Sprycel with or without food. Imatinib (Gleevec) — Take with a meal and a large glass of water. Ponatinib (Iclusig) — Take with or without food. ...
... People with blast-phase CML may receive newer TKIs such as: Nilotinib (Tasigna) Dasatinib (Sprycel) Bosutinib (Bosulif) These medications may be more effective if you’ve never taken them before. If other TKIs don’t work well, you may be prescribed ponatinib (Iclusig) or asciminib (Scemblix). ...
How Is AML Different From CML Blast Crisis?
... People with blast-phase CML may receive newer TKIs such as: Nilotinib (Tasigna) Dasatinib (Sprycel) Bosutinib (Bosulif) These medications may be more effective if you’ve never taken them before. If other TKIs don’t work well, you may be prescribed ponatinib (Iclusig) or asciminib (Scemblix). ...
... Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy and are the most common CML treatment.Your hematology specialist may recommend a TKI such as nilotinib (sold as Danziten or Tasigna), imatinib (Gleevec), dasatinib (Sprycel), bosutinib (Bosulif), ponatinib (Iclusig), or asciminib (Scemblix).Side effects may include: Fatigue (tiredness ...
CML Treatment Side Effects: 5 Tips for Relief
... Tyrosine kinase inhibitors (TKIs) are a type of targeted therapy and are the most common CML treatment.Your hematology specialist may recommend a TKI such as nilotinib (sold as Danziten or Tasigna), imatinib (Gleevec), dasatinib (Sprycel), bosutinib (Bosulif), ponatinib (Iclusig), or asciminib (Scemblix).Side effects may include: Fatigue (tiredness ...
... Other TKIs that your doctor may recommend include: Dasatinib (Sprycel) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) ChemotherapyChemotherapy is the use of drugs to treat cancer by killing rapidly growing cancer cells. ...
Identifying and Managing CML Blast Crisis
... Other TKIs that your doctor may recommend include: Dasatinib (Sprycel) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib (Iclusig) Asciminib (Scemblix) ChemotherapyChemotherapy is the use of drugs to treat cancer by killing rapidly growing cancer cells. ...
... Food and Drug Administration to treat CML: Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (Danziten and Tasigna) Ponatinib (Iclusig) Because TKIs usually work so well, doctors don’t use other drugs as often. However, in some cases, another treatment option is needed. ...
Chronic Myeloid Leukemia (CML): An Overview
... Food and Drug Administration to treat CML: Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (Danziten and Tasigna) Ponatinib (Iclusig) Because TKIs usually work so well, doctors don’t use other drugs as often. However, in some cases, another treatment option is needed. ...
... TKIs include drugs like imatinib (sold as Gleevec) or dasatinib (sold as Sprycel). TKIs target a specific gene change called BCR-ABL, which is almost always found in CML cells. These drugs are often very effective at keeping leukemia under control. However, sometimes, they may be ineffective. ...
Interferon Therapy for Leukemia: When Is It Used?
... TKIs include drugs like imatinib (sold as Gleevec) or dasatinib (sold as Sprycel). TKIs target a specific gene change called BCR-ABL, which is almost always found in CML cells. These drugs are often very effective at keeping leukemia under control. However, sometimes, they may be ineffective. ...
... Examples of TKIs include: Asciminib (Scemblix) Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (sold under brand names Tasigna and Danziten) Ponatinib (Iclusig) Common side effects of these medications include: Nausea and vomiting Diarrhea Fatigue or extreme tiredness Headache Skin rashes Fever Edema (swelling caused by fluid buildup ...
4 Facts About CML Therapy: Side Effects, Hidden Barriers, and More
... Examples of TKIs include: Asciminib (Scemblix) Bosutinib (Bosulif) Dasatinib (Sprycel) Imatinib (Gleevec) Nilotinib (sold under brand names Tasigna and Danziten) Ponatinib (Iclusig) Common side effects of these medications include: Nausea and vomiting Diarrhea Fatigue or extreme tiredness Headache Skin rashes Fever Edema (swelling caused by fluid buildup ...
... I also have a decreased appetite now.”Members also report having constipation while taking dasatinib (Sprycel), venetoclax (Venclexta), and rituximab (Rituxan).Tell your oncologist if you are experiencing stomach bloating or abdominal pain you suspect may be side effects of cancer treatment. ...
Is Stomach Bloating a Symptom of Leukemia?
... I also have a decreased appetite now.”Members also report having constipation while taking dasatinib (Sprycel), venetoclax (Venclexta), and rituximab (Rituxan).Tell your oncologist if you are experiencing stomach bloating or abdominal pain you suspect may be side effects of cancer treatment. ...
... Food and Drug Administration has approved four TKIs that can be used right after being diagnosed with CML: Imatinib (Gleevec) Dasatinib (Sprycel) Bosutinib (Bosulif) Nilotinib (Tasigna) If these targeted therapies don’t work to control CML, ponatinib (Iclusig) may also be an option. ...
The Benefits of Targeted Therapy for Leukemia
... Food and Drug Administration has approved four TKIs that can be used right after being diagnosed with CML: Imatinib (Gleevec) Dasatinib (Sprycel) Bosutinib (Bosulif) Nilotinib (Tasigna) If these targeted therapies don’t work to control CML, ponatinib (Iclusig) may also be an option. ...
Join
Your Privacy Choices
